Kirkland, WA, May 8, 2024 – Verasonics, Inc., the leader in research ultrasound, announces a new OEM Supply Model to enhance corporate commercialization efforts for customers bringing ultrasound-based solutions to market.

Verasonics’ commercial suite of solutions now offers the Commercial Technology Licensing Model and the OEM Supply Model. Both use Verasonics’ industry-leading technology to assist corporate customer development and commercialization efforts.

“Verasonics has collaborated with a wide range of companies around the world by licensing our industry-leading ultrasound technology and software development approach to their teams. These collaborations have supported the development of applications including Focused Ultrasound, Breast Imaging, Renal Denervation, Drug Delivery, and Neuro,” said Jon K. Daigle, President and Chief Executive Officer at Verasonics. “By working with Verasonics and utilizing our innovative development platform, commercial licensees achieve substantial savings in development costs and improved time to market.”

Mr. Daigle added, “We are excited to add the OEM Supply Model to our suite of offerings available to commercial customers. This program offers our customers additional flexibility and an alternate path for commercial supply.”

For more information on Verasonics’ commercial suite of solutions, please contact [email protected].